INS and hydrops fetalis: Although thiazolidinediones activate the peroxisome proliferator-activated receptor γ (PPARγ) system and improve insulin sensitivity to reduce cardiovascular events [26], they are reported to be associated with an increased risk of HF by augmentation of fluid retention [27].